ORPN - Bioblast Pharma Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.1500
-0.1000 (-4.4444%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.2500
Open2.2800
Bid1.7500 x 100
Ask2.3000 x 100
Day's Range2.1374 - 2.2900
52 Week Range1.4900 - 5.9900
Volume19,762
Avg. Volume57,882
Market Cap7.186M
Beta0.88
PE Ratio (TTM)N/A
EPS (TTM)-2.5670
Earnings DateFeb 22, 2018 - Feb 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
Trade prices are not sourced from all markets
  • What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?
    Simply Wall St.12 days ago

    What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?

    If you are looking to invest in Bioblast Pharma Ltd’s (NASDAQ:ORPN), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?
    Simply Wall St.2 months ago

    Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?

    I am going to take a deep dive into Bioblast Pharma Ltd’s (NASDAQ:ORPN) most recent ownership structure, not a frequent subject of discussion among individual investors. A company’s ownership structureRead More...

  • Benzinga3 months ago

    ICYMI: Shutterfly Downgrade, BioBlast Price Action, Blockchain ETFs

    In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 17, 2018. Blockchain ETFs’ Inaugural Trading Session Wayne Duggan breaks down the arrival of new ETFs - Reality Shares ...

  • Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?
    Simply Wall St.6 months ago

    Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?

    Bioblast Pharma Ltd (NASDAQ:ORPN), a USD$7.59M small-cap, operates in the healthcare industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as an aging population,Read More...

  • Associated Press6 months ago

    Bio Blast reports 3Q loss

    The Tel Aviv, Israel-based company said it had a loss of 32 cents per share. The company's shares closed at $2.27. A year ago, they were trading at $7.15. _____ This story was generated by Automated Insights ...

  • Associated Press9 months ago

    Bio Blast reports 2Q loss

    On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 10 cents. In the final minutes of trading on Friday, the company's shares hit 64 cents. A year ago, they were trading at $1.58. ...

  • Associated Press11 months ago

    Bio Blast reports 1Q loss

    The Tel Aviv, Israel-based company said it had a loss of 16 cents per share. In the final minutes of trading on Friday, the company's shares hit 45 cents. A year ago, they were trading at $2.08. _____ ...